Alkermes Results Presentation Deck
June 2021, 31 slides
  1. Alkermes
  2. Related Decks
  3. Results Presentation Decks
alfa artistry and artistry clinical study update society of clinical oncology annual meeting updates a | Alkermes
forward looking statements | Alkermes
today participants els las | Alkermes
alfa clinical trials overview | Alkermes
alfa unique designed to harness validated pathway biology | Alkermes
alfa development program progress | Alkermes
overview of clinical development program | Alkermes
artistry data updates | Alkermes
artistry study design | Alkermes
artistry safety summary | Alkermes
artistry cohort enrollment completed | Alkermes
artistry responses in melanoma patients | Alkermes
anti tumor activity in melanoma | Alkermes
artistry responses in renal cell carcinoma patients | Alkermes
anti tumor activity in renal cell carcinoma | Alkermes
artistry combination cohorts enrollment completed | Alkermes
artistry in combination with unapproved tumor types | Alkermes
artistry in combination with best response of target lesion in unapproved tumors | Alkermes
artistry in combination with approved tumor cohort and tumor specific cohorts | Alkermes
artistry in combination with best response of target lesion in approved tumors | Alkermes
artistry data summary | Alkermes
artistry data updates | Alkermes
artistry phase efficacy expansion initiated following determination of subcutaneous | Alkermes
safety profile of subcutaneous consistent with mechanism of action and | Alkermes
demonstrated dose dependent pharmacodynamic response similar to | Alkermes
selectively expanded circulating and cells and demonstrated initial anti tumor activity | Alkermes
artistry in combination with case study year old female with high grade serous | Alkermes
artistry data summary | Alkermes
program summary | Alkermes
panel discussion with and | Alkermes
alkermes las | Alkermes
See More
Alkermes
Results Presentation Decks
Drug Manufacturers—Specialty & Generic Decks
Healthcare Decks
Related Content
Articles:
Barbarians at the Gate
Explore Topics
Monotherapy
Tumor
Melanoma
Cancer
Recent decks by Alkermes
Investor Conference
January 2024
Results
October 2023
Investor Presentation
October 2023
Results
July 2023
See all presentations by Alkermes (22 decks)
Related decks
Immatics
Investor Presentation
November 2023
BioAtla
Investor Presentation
August 2022
BioAtla
Investor Presentation
January 2024
Immatics
Results
October 2022
BioAtla
Investor Presentation
November 2022
CG Oncology
IPO
March 2024
Apexigen
SPAC
March 2022
BioNTech
Results
August 2021
Recent decks by Alkermes
See all presentations (22 decks)
Investor Conference
January 2024
Results
October 2023
Investor Presentation
October 2023
Results
July 2023
Immatics
Investor Presentation
November 2023
BioAtla
Investor Presentation
August 2022
BioAtla
Investor Presentation
January 2024
Immatics
Results
October 2022
BioAtla
Investor Presentation
November 2022
CG Oncology
IPO
March 2024
Apexigen
SPAC
March 2022
BioNTech
Results
August 2021
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights